Bayer's plea for stay on Nexavar generic in India dismissed

(Reuters) - An Indian patents appeals board on Friday dismissed Bayer AG's petition seeking a stay on the "compulsory license" issued to India's Natco Pharma for selling generic copies of cancer drug Nexavar in India, a spokesman...

Source: http://health.yahoo.net/news/s/nm/bayer-s-plea-for-stay-on-nexavar-generic-in-india-dismissed

Jesus Receipt design John Edwards Jorja Fox